Amgen (AMGN) PT Raised to $381 at Piper Sandler
Tweet Send to a Friend
Piper Sandler analyst David Amsellem raised the price target on Amgen (NASDAQ: AMGN) to $381.00 (from $342.00) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
